Industry News - Tag: FDA

You can read our Premium News Service in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.

Regulatory in brief / CBD, Norway, COVID-19

23 December 2020

The US Food and Drug Administration (FDA) has issued a number of warning letters to cannabidiol (CBD) companies, the Norwegian Medicines Agency (NoMA) is expanding the list of general-sale medicines, and the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has issued an exceptional us...

Read the full story

Regulatory in brief | NSAIDs, codeine, CMDh

22 October 2020

The US Food and Drug Administration (FDA) has implemented labelling changes for non-steroidal anti-inflammatory drugs (NSAIDs), New Zealand has confirmed the date for reverse-switching all medicines containing codeine from non-prescription to prescription status, and Europe's Coordination Group for...

Read the full story

Regulatory in brief | Europe, global collaboration, US

28 April 2020

In response to the COVID-19 pandemic, the European Council has adopted the European Commission’s proposal to postpone by one year the date of application of the new Medical Devices Regulation, regulatory agencies around the world have stepped up global collaboration, and the US has taken action on h...

Read the full story

Regulatory in brief | France, the UK, the US

21 April 2020

In response to the COVID-19 pandemic, France has warned people to stop taking certain food supplements if they have COVID-19, the UK has issued advice on the use of ibuprofen and COVID-19, and the US has authorised the first diagnostic test for COVID-19 with at-home sample collection.

Read the full story